LPL Financial’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,300
| Closed | -$19.7K | – | 5224 |
|
|
2024
Q4 | $19.7K | Hold |
2,300
| – | – | ﹤0.01% | 5078 |
|
|
2024
Q3 | $49.3K | Buy |
2,300
+250
| +12% | +$5.36K | ﹤0.01% | 4894 |
|
|
2024
Q2 | $46.7K | Sell |
2,050
-458
| -18% | -$10.4K | ﹤0.01% | 4744 |
|
|
2024
Q1 | $112K | Hold |
2,508
| – | – | ﹤0.01% | 4581 |
|
|
2023
Q4 | $158K | Sell |
2,508
-335
| -12% | -$21K | ﹤0.01% | 4389 |
|
|
2023
Q3 | $207K | Sell |
2,843
-287
| -9% | -$20.9K | ﹤0.01% | 4158 |
|
|
2023
Q2 | $200K | Buy |
3,130
+187
| +6% | +$11.9K | ﹤0.01% | 4108 |
|
|
2023
Q1 | $104K | Hold |
2,943
| – | – | ﹤0.01% | 4170 |
|
|
2022
Q4 | $69.4K | Buy |
2,943
+1,779
| +153% | +$42K | ﹤0.01% | 4202 |
|
|
2022
Q3 | $43K | Sell |
1,164
-100
| -8% | -$3.69K | ﹤0.01% | 4214 |
|
|
2022
Q2 | $65K | Sell |
1,264
-450
| -26% | -$23.1K | ﹤0.01% | 4165 |
|
|
2022
Q1 | $117K | Sell |
1,714
-125
| -7% | -$8.53K | ﹤0.01% | 3934 |
|
|
2021
Q4 | $150K | Buy |
1,839
+187
| +11% | +$15.3K | ﹤0.01% | 4046 |
|
|
2021
Q3 | $182K | Hold |
1,652
| – | – | ﹤0.01% | 3987 |
|
|
2021
Q2 | $186K | Hold |
1,652
| – | – | ﹤0.01% | 3901 |
|
|
2021
Q1 | $184K | Buy |
1,652
+580
| +54% | +$64.6K | ﹤0.01% | 3763 |
|
|
2020
Q4 | $108K | Buy |
1,072
+650
| +154% | +$65.5K | ﹤0.01% | 3650 |
|
|
2020
Q3 | $28K | Sell |
422
-75
| -15% | -$4.98K | ﹤0.01% | 3467 |
|
|
2020
Q2 | $34K | Buy |
497
+225
| +83% | +$15.4K | ﹤0.01% | 3351 |
|
|
2020
Q1 | $14K | Buy |
+272
| New | +$14K | ﹤0.01% | 3153 |
|
|
2019
Q3 | – | Sell |
-22
| Closed | -$5K | – | 3287 |
|
|
2019
Q2 | $5K | Hold |
22
| – | – | ﹤0.01% | 3252 |
|
|
2019
Q1 | $6K | Hold |
22
| – | – | ﹤0.01% | 3160 |
|
|
2018
Q4 | $6K | Buy |
+22
| New | +$6K | ﹤0.01% | 3044 |
|